Skip to content

A clinical study on the effect of "four stages and three methods" of the national famous traditional Chinese medicine medicine You Zhaoling on the pregnancy outcome of IVF-ET patients with tubal infertility

A clinical study on the effect of "four stages and three methods" of the national famous traditional Chinese medicine medicine You Zhaoling on the pregnancy outcome of IVF-ET patients with tubal infertility

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000669
Enrollment
Unknown
Registered
2025-04-07
Start date
2024-04-01
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

Control group:IVF-ET is treated with conventional western medicine
Treatment group:IVF-ET+ four phases and three methods

Sponsors

The Second Hospital of Hunan University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
21 Years to 42 Years

Inclusion criteria

Inclusion criteria: 1: Meet the diagnostic criteria for tubal infertility; 2: Female 21 years old= age = 42 years; 3: Patients who meet the indications of IVF-ET and intend to undergo IVF-ET of fresh embryos; 4: Have not received TCM treatment for infertility in the past 3 months; 5: Not participating in other clinical studies at the same time; 6: This stimulation regimen is a long regimen of gonadotropin-releasing hormone agonist (GnRH-a); 7: Signed informed consent.

Exclusion criteria

Exclusion criteria: (1) The patient suffers from severe systemic organic diseases such as heart liver kidney etc. or suffers from severe wasting diseases malignant tumors and other diseases that make it difficult to achieve pregnancy; (2) The patient suffers from uterine malformations such as unicornuate uterus bicornuate uterus etc.; or other untreated reproductive diseases that can affect the ovaries and endometrium such as low ovarian reserve intrauterine adhesions polycystic ovary syndrome etc.; (3) chromosomal abnormalities of the patient or partner (except for chromosomal polymorphisms); (4) Patients or partners with severe mental disorders such as bipolar disorder bipolar disorder etc. are not suitable to participate in this study (5) gametes are provided and both parties have been exposed to radiation or chemicals that may cause embryonic malformations and are still in the active period; (6) Patients who have a tendency to bleed or are prone to infection or who have severe allergic diseases or local skin ulcers or scars that prohibit acupuncture;

Design outcomes

Primary

MeasureTime frame
Embryo quality;Endometrial thickness and type;Clinical pregnancy outcomes;

Secondary

MeasureTime frame
Progesterone;Estradiol;Anxiety depressed mood state;

Countries

China

Contacts

Public ContactLiu Wei ai

The Second Hospital of Hunan University of Chinese Medicine

55999630@qq.com13787016026

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026